Wallace Advisory Group LLC raised its position in shares of Oracle Co. (NYSE:ORCL - Free Report) by 29.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,340 shares of the enterprise software provider's stock after buying an additional 1,922 shares during the quarter. Oracle comprises 0.8% of Wallace Advisory Group LLC's portfolio, making the stock its 25th biggest holding. Wallace Advisory Group LLC's holdings in Oracle were worth $1,166,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of ORCL. McClarren Financial Advisors Inc. lifted its holdings in shares of Oracle by 201.7% in the 4th quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider's stock worth $266,000 after buying an additional 1,069 shares during the period. Boston Trust Walden Corp raised its stake in Oracle by 40.8% in the fourth quarter. Boston Trust Walden Corp now owns 564,030 shares of the enterprise software provider's stock valued at $93,990,000 after buying an additional 163,543 shares during the last quarter. CENTRAL TRUST Co increased its holdings in shares of Oracle by 10.8% in the fourth quarter. CENTRAL TRUST Co now owns 43,851 shares of the enterprise software provider's stock valued at $7,307,000 after purchasing an additional 4,259 shares during the period. EQ Wealth Advisors LLC acquired a new position in shares of Oracle in the fourth quarter valued at about $12,738,000. Finally, Paul R. Ried Financial Group LLC acquired a new position in shares of Oracle in the fourth quarter valued at about $500,000. Institutional investors own 42.44% of the company's stock.
Analyst Ratings Changes
ORCL has been the topic of several analyst reports. Mizuho dropped their target price on Oracle from $210.00 to $180.00 and set an "outperform" rating on the stock in a report on Tuesday, April 15th. Evercore ISI decreased their target price on Oracle from $200.00 to $185.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. Monness Crespi & Hardt upgraded Oracle from a "sell" rating to a "neutral" rating in a research report on Monday, March 3rd. Royal Bank of Canada set a $145.00 target price on Oracle and gave the stock a "sector perform" rating in a research note on Tuesday, March 11th. Finally, Citigroup cut their target price on Oracle from $194.00 to $160.00 and set a "neutral" rating for the company in a research note on Wednesday, March 12th. Fourteen analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $174.42.
View Our Latest Stock Analysis on ORCL
Insiders Place Their Bets
In other Oracle news, Director Leon E. Panetta sold 5,000 shares of the business's stock in a transaction on Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the sale, the director now owns 58,090 shares in the company, valued at $7,538,339.30. The trade was a 7.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Naomi O. Seligman sold 2,866 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $149.53, for a total value of $428,552.98. Following the transaction, the director now owns 31,764 shares of the company's stock, valued at $4,749,670.92. This represents a 8.28% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,366 shares of company stock worth $4,015,723 over the last quarter. 42.20% of the stock is owned by corporate insiders.
Oracle Trading Up 0.6%
Shares of ORCL stock traded up $0.92 during mid-day trading on Monday, hitting $166.45. 7,164,637 shares of the company's stock were exchanged, compared to its average volume of 9,517,834. Oracle Co. has a fifty-two week low of $117.34 and a fifty-two week high of $198.31. The stock has a 50-day simple moving average of $144.55 and a two-hundred day simple moving average of $160.88. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. The stock has a market cap of $465.55 billion, a price-to-earnings ratio of 40.70, a PEG ratio of 3.46 and a beta of 1.27.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.49 by ($0.02). The firm had revenue of $14.13 billion during the quarter, compared to analysts' expectations of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business posted $1.41 earnings per share. Equities analysts expect that Oracle Co. will post 5 EPS for the current fiscal year.
Oracle Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date was Thursday, April 10th. This is a boost from Oracle's previous quarterly dividend of $0.40. Oracle's payout ratio is currently 46.95%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report